Related content

Human T-cells recognise N-terminally Fmoc-modified peptide

By Mannering S.I.   Purcell A.W.   Honeyman M.C.   McCluskey J.   Harrison L.C.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3638-3646

Elsevier

Access to resources Recommend Favorite

Activation and functional capacity of human neonatal CD4 T-cells

By Reen D.J.  

Vaccine, Vol. 16, Iss. 14, 1998-08 ,pp. : 1401-1408

Elsevier

Access to resources Recommend Favorite

Application of murine T-T hybridoma cells to in vitro potency assay of human synthetic peptide vaccines

By Sheue C.T.Y.   Nag B.  

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1313-1321

Elsevier

Access to resources Recommend Favorite

Strain-dependent in vitro and in vivo effects of oleic acid anilides on splenocytes and T cells in a murine model of the toxic oil syndrome

By Bell S.A.   Kuntze I.   Caputo A.   Chatelain R.  

Food and Chemical Toxicology, Vol. 40, Iss. 1, 2002-01 ,pp. : 19-24

Elsevier

Access to resources Recommend Favorite

Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen

By Jain S.L.   Barone K.S.   Flanagan M.P.   Michael J.G.  

Vaccine, Vol. 14, Iss. 1, 1996-01 ,pp. : 42-48

Elsevier

Access to resources Recommend Favorite